Top
Phillips Lab
Home Research Publications Team News Contact Support Us
HomeResearchPublicationsTeamNewsContactSupport Us
Phillips Lab
tagline font
Epigenomic Reprogramming as a Driver of Malignant Glioma.
Tarah B.June 14, 2020
Facebook0 Twitter Pinterest0 0 Likes
Previous

A Chemical Strategy toward Novel Brain-Penetrant EZH2 Inhibitors.

Tarah B.December 8, 2022
Next

Target Identification Reveals Lanosterol Synthase as a Vulnerability in Glioma.

Tarah B.June 14, 2020
University of Pennsylvania, Stemmler Hall
3450 Hamilton Walk,
Philadelphia, PA, 19104,
United States
617-838-7740 rphillips@upenn.edu
Hours
Mon 8am to 5pm
Tue 8am to 5pm
Wed 8am to 5pm
Thu 8am to 5pm
Fri 8am to 5pm
Sat Closed
Sun Closed
PublicationsTeamNewsContactSupport UsWiki

Department of Neurology, University of Pennsylvania, CRB520, 415 Curie Boulevard, Philadelphia, PA 19104 •  richard.phillips@pennmedicine.upenn.edu

© 2020 Phillips Lab. All Rights Reserved. • Site Design